Inverness Medical Innovations has said that it has completed the acquisition of ParadigmHealth. The transaction was structured as an all cash deal, with a purchase price of approximately $230 million.
Subscribe to our email newsletter
The company is operating profitably and the past twelve months revenues were approximately $58.5 million.
ParadigmHealth, based in New Jersey, is a leading provider of innovative, consumer-centric decision support technologies and expert coaching to facilitate better health choices for acutely ill and clinically complex patients, including neonatal intensive care and oncology patients.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.